Research Associate

Email: jl844@medschl.cam.ac.uk

ORCID is 0000-0003-0399-5464

Background

EDUCATION

2008-2012: PhD studentship in Genetic Epidemiology funded by the French Ministry of Research and the Fondation de France, Paris, France, University of Paris-Sud 11, Le Kremlin-Bicêtre, France, Dissertation: Modifying factors of breast cancer risk in women carrying a BRCA1 and BRCA2 mutation. Supervisor: Dr Nadine Andrieu
2006-2008: Master in Public Health, Statistical Genetics, University of Paris-Sud 11, Le Kremlin-Bicêtre, France
2004-2006: Bachelor of Science, Biology and Developmental Biology, University of Paris-Sud 11, Orsay, France

PROFESSIONAL EXPERIENCE

2015- : Research Associate, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK
2014-2015: Postdoctoral Fellowship, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK
2012-2014: Research assistant, Institut Curie/Inserm U900/Mines ParisTech, Paris, France
2008-2011: Assistant Graduate Teaching, Statistics, University of Paris-Sud 11, Orsay, France
2007: Internship (7 months), Inserm U750/Health Economics Laboratory, Le Kremlin-Bicêtre, France
2005: Internship, IBAIC/Amphibian Transgenesis and Genetics Laboratory, Orsay, France

Research

Julie’s research focuses on the genetic epidemiology of breast cancer. She is involved in the quality control and the analyses of data obtained by the BCAC consortium.

Selected Publications

Lecarpentier J, Noguès C, Mouret-Fourme E, Buecher B, Gauthier-Villars M, Stoppa-Lyonnet D, Bonadona V, Fricker JP, Berthet P, Caron O, Coupier I, Pujol P, Faivre L, Gesta P, Eisinger F, Mari V, Gladieff L, Lortholary A, Luporsi E, Leroux D, Venat-Bouvet L, Maugard CM, Colas C, Tinat J, Lasset C, Andrieu N: Breast cancer risk associated with oestrogen exposure and truncating mutation location in BRCA1/2 carriers. Cancer Epidemiol Biomarkers Prev. 2015 Jan 22. pii: cebp.0884.2014.

Lecarpentier J, Noguès C, Mouret-Fourme E, Gauthier-Villars M, Lasset C, Fricker J.P, Caron O, Stoppa-Lyonnet D, Berthet P, Faivre L, Bonadona V, Buecher B, Coupier I, Gladieff L, Gesta P, Eisinger F, Frénay M, Luporsi E, Lortholary A, Colas C, Dugast C, Longy M, Pujol P, Tinat J, GENEPSO , Lidereau R, Andrieu N: Variation in breast cancer risk associated with factors related to pregnancies according to truncating mutation location, in the French National BRCA1 and BRCA2 mutations carrier cohort (GENEPSO). Breast Cancer Research, Breast Cancer Res. 2012 Jul 3;14(4):R99.

Lecarpentier J, Nogues C, Mouret-Fourme E, Stoppa-Lyonnet D, Lasset C, Caron O, Fricker JP, Gladieff L, Faivre L, Sobol H, Gesta P, Frenay M, Luporsi E, Coupier I, Lidereau R, Andrieu N: Variation in breast cancer risk with mutation position, smoking, alcohol, and chest X-ray history, in the French National BRCA1/2 carrier cohort (GENEPSO). Breast Cancer Research Treatment 2011, 130(3):927-38.

Lecarpentier J, Noguès C, Mouret-Fourme E, Lidereau R, Andrieu N, GENEPSO – Groupe “Génétique et Cancer” Collaboration(s): Variation of breast cancer risk in the French national BRCA1/2 carrier cohort (GENEPSO). Genetic Epidemiology 2009, 33:819.

Bronchain OJ, Pollet N, Ymlahi-Ouazzani Q, Dhorne-Pollet S, Helbling JC, Lecarpentier JE, Percheron K, Wegnez M. The olig family: phylogenetic analysis and early gene expression in Xenopus tropicalis. Dev Genes Evol. 2007 Jul;217(7):485-97. Epub 2007 Jun 7.